Point72 Asset Management, L.P. 13D and 13G filings for Regulus Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:33 pm Sale |
2021-12-31 | 13G | Regulus Therapeutics Inc. RGLS |
Point72 Asset Management, L.P. | 241,158 1.600% |
-321,544 (-57.14%) |
Filing |
| 2020-12-09 5:13 pm Purchase |
2020-12-04 | 13G | Regulus Therapeutics Inc. RGLS |
Point72 Asset Management, L.P. | 562,701 8.500% |
562,701 (New Position) |
Filing |